162 related articles for article (PubMed ID: 30882701)
1. Can surgical treatment be justified for neuroendocrine carcinoma of the gallbladder?
You YH; Choi DW; Heo JS; Han IW; Choi SH; Jang KT; Han S
Medicine (Baltimore); 2019 Mar; 98(11):e14886. PubMed ID: 30882701
[TBL] [Abstract][Full Text] [Related]
2. Clinical diagnosis and treatment of 37 cases of gallbladder neuroendocrine carcinoma.
Liu F; Miao W; Nan J; Shi Z; Zhang A; Bo Y; Xu J
World J Surg Oncol; 2024 Jun; 22(1):157. PubMed ID: 38877554
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
Yun SP; Shin N; Seo HI
World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma.
Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z
Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
6. Role of radical surgery in patients with stage IV gallbladder cancer.
Kang MJ; Song Y; Jang JY; Han IW; Kim SW
HPB (Oxford); 2012 Dec; 14(12):805-11. PubMed ID: 23134181
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine Carcinoma of Gallbladder: A Step Beyond Palliative Therapy, Experience of 25 Cases.
Kanetkar AV; Patkar S; Khobragade KH; Ostwal V; Ramaswamy A; Goel M
J Gastrointest Cancer; 2019 Jun; 50(2):298-303. PubMed ID: 29435905
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes analysis of Gallbladder neuroendocrine carcinoma.
Jiang M; Zhang Y
J Cancer Res Ther; 2023 Aug; 19(4):910-916. PubMed ID: 37675716
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Features and Surgical Outcomes of Neuroendocrine Carcinoma of the Gallbladder.
Tanioka N; Okabayashi T; Sui K; Matsumoto T; Iwata J; Morita S; Shimada Y
Surg Technol Int; 2019 May; 34():101-106. PubMed ID: 30888678
[TBL] [Abstract][Full Text] [Related]
10. Gallbladder neuroendocrine carcinoma: A report of two cases and literature review.
Liao Y; Cao W; Li Z; Xu X; Zhang Y; Liu Z; Miao J; Zhou Y; Zhen Z; Liu D; Li H; Chai L; Wei Y; Zhang X; Zhang L; Wang J; Tian Y
Oncol Lett; 2023 Jun; 25(6):229. PubMed ID: 37153064
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis.
Do MY; Jang SI; Kang HP; Kim EJ; Lee KJ; Park GE; Lee SJ; Lee DK; Woo SM; Cho JH
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572940
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and prognostic factors of patients with primary gallbladder neuroendocrine carcinomas.
Wang W; Yang CX; Yu XZ; Zhang SL; Wang J; Wang J
J Dig Dis; 2022 Mar; 23(3):166-173. PubMed ID: 35187836
[TBL] [Abstract][Full Text] [Related]
13. Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review.
Cai XC; Wu SD
World J Clin Cases; 2022 Aug; 10(23):8212-8223. PubMed ID: 36159526
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine carcinoma of gallbladder: a case series and literature review.
Liu W; Chen W; Chen J; Hong T; Li B; Qu Q; He X
Eur J Med Res; 2019 Feb; 24(1):8. PubMed ID: 30717775
[TBL] [Abstract][Full Text] [Related]
15. Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma and Comparison with Gallbladder Adenocarcinoma Using a Propensity Score Matching.
Yan S; Wang Y; Chen X; Zhang Y; Huang Z; Zhao J; Zhou J; Li Z; Bi X; Luo Z; Cai J; Zhao H
Cancer Manag Res; 2020; 12():1437-1446. PubMed ID: 32161496
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder neuroendocrine carcinoma: A single center experience.
Chu H; Zhang C; Shi Y; Wu W; Hu Z; Zhang J; Huang D
Medicine (Baltimore); 2020 Sep; 99(36):e21912. PubMed ID: 32899024
[TBL] [Abstract][Full Text] [Related]
17. Update in clinical management for gallbladder neuroendocrine carcinoma.
Chu H; Shi Y; Liu J; Huang D; Zhang J; Dou C
Medicine (Baltimore); 2021 Apr; 100(14):e25449. PubMed ID: 33832150
[TBL] [Abstract][Full Text] [Related]
18. A rare occurrence of a poorly differentiated large cell neuroendocrine carcinoma of the gallbladder: A case report and review of the literature.
Shaikh S; Abouzead L; Leone C; Talishinskiy T
Int J Surg Case Rep; 2023 Aug; 109():108476. PubMed ID: 37494780
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of adjuvant chemoradiation and predictors of survival after extended cholecystectomy in gall bladder carcinoma: a single institution experience from an endemic region.
Agrawal S; Gupta PK; Rastogi N; Lawrence A; Kumari N; Das KJ; Saxena R
J Gastrointest Cancer; 2015 Mar; 46(1):48-53. PubMed ID: 25511013
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study).
Bergquist JR; Shah HN; Habermann EB; Hernandez MC; Ivanics T; Kendrick ML; Smoot RL; Nagorney DM; Borad MJ; McWilliams RR; Truty MJ
Int J Surg; 2018 Apr; 52():171-179. PubMed ID: 29496648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
